|Year : 2019 | Volume
| Issue : 1 | Page : 8-14
A 35-year standardized prediction estimates for gynecological lesions in oil and gas exploration and production city in the Niger Delta
M Onyije Felix1, A Ngokere Ajuluchukwu2, E Ligha Aloysius3, O Mgbere Osaro4, O Avwioro Godwin5
1 Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Wilberforce Island, Bayelsa State; Department of Medical Laboratory Science, Faculty of Health Science and Technology, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria
2 Department of Medical Laboratory Science, Faculty of Health Science and Technology, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria
3 Department of Human Anatomy, Faculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Wilberforce Island, Bayelsa State, Nigeria
4 Institute of Community Health, University of Houston, Texas Medical Center, Houston, Texas, USA
5 Faculty of Science, Delta State University, Abraka, Nigeria
|Date of Web Publication||17-Apr-2019|
Dr. M Onyije Felix
Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Wilberforce Island, PMB 071, Bayelsa State
Source of Support: None, Conflict of Interest: None
Background: The impact of constant emission of hydrocarbons and contaminated water level through oil spillage in the oil and gas exploration and production areas of Niger Delta on women's health cannot be underestimated. We developed a 35-year standardized prediction estimates for gynecological lesions using data obtained from an integrated specialist hospital serving the residence of the oil and gas exploration and production City of Port Harcourt and the surrounding areas of Niger Delta, Nigeria.
Methods: The study participants comprised of 697 females who received medical care at the Braithwaite Memorial Specialist Hospital (BMSH), Port Harcourt, Rivers State, Nigeria, between 2010 and 2014. Predictive modeling of the diseases was performed using JMP statistical discovery™ software, version 12.0 (SAS Institute, Cary, NC, USA).
Results: The distribution of the gynecological lesions (n = 697) differed significantly (P < 0.001) by year of diagnosis, developmental stage, age category, and types of lesion. The mean age of study participants was 39.1 ± 12.8 years, and most of the lesions (61.8%) occurred among females who were 30- to 49-year old. Leiomyoma recorded the highest 5-year standardized prevalence rate of 0.508, and with no intervention, it is estimated that the number of cases diagnosed will rise from 235 in 2015 to 1883 by the year 2050. This was followed by ovarian cyst with a prevalence rate of 0.124 and projected increase from 57 in 2015 to 461 by the year 2050. Similarly, the product of conception is also estimated to increase from 34 to 277 by the year 2050.
Conclusion: The over 700% increased prediction of gynecological lesions by 2050 calls for urgent attention by both governmental and private agencies to fund awareness campaigns and screenings for women, especially for those residing in the oil- and gas-producing areas of Niger Delta.
Keywords: Gynecological lesions; Niger Delta; Nigeria; prediction estimates.
|How to cite this article:|
Felix M O, Ajuluchukwu A N, Aloysius E L, Osaro O M, Godwin O A. A 35-year standardized prediction estimates for gynecological lesions in oil and gas exploration and production city in the Niger Delta. Trop J Obstet Gynaecol 2019;36:8-14
|How to cite this URL:|
Felix M O, Ajuluchukwu A N, Aloysius E L, Osaro O M, Godwin O A. A 35-year standardized prediction estimates for gynecological lesions in oil and gas exploration and production city in the Niger Delta. Trop J Obstet Gynaecol [serial online] 2019 [cited 2020 Feb 17];36:8-14. Available from: http://www.tjogonline.com/text.asp?2019/36/1/8/256475
| Introduction|| |
With the rapid growth in population, prediction models and forecasts have become more important in our localities. Over the next 50 years, gynecological lesions are projected to change due to population growth, which is one of the largest contributors to the increasing total number of gynecological cases., The world population as at 2015 was 7.3 billion and Nigeria population was put at 183.5 million; this number is expected to increase to 9.7 billion and 440 million in the world and Nigeria, respectively, by 2050.,,
The recent alarm on rising global incidence of lesions by the World Health Organization (WHO) should worry African countries, including Nigeria. Cancer killed 7.6 million persons in 2008 worldwide, and there is indication that the figure could double to 13 million by 2030. Cancer accounts for 13% of all deaths registered globally and 70% of that figure occurred in middle- and low-income countries. It is on record that about 10,000 cancer deaths occurs annually in Nigeria, whereas 250,000 new cases are recorded yearly with two-third of the deaths and new cancer cases recorded being as a result of shortage of functional cancer control programs in Nigeria.
Since gynecological lesions frequently occur in relatively younger women, its toll in reducing life span is considerable. There have been concerns worldwide and especially in the developing countries because of the significant contribution of these conditions on morbidity and mortality., Data on gynecological lesions in some developing countries show a preponderance of cancer of the cervix., Cervical carcinoma in developing countries accounts for 80% of the estimated 231,000 deaths that occurred from it annually.,,, The incidence and prevalence of other female genital lesions vary from one geographical region to another. The wide global variation in incidence indicates that the impact of the various gynecological lesions would be much reduced by application of current knowledge of populations with high-incidence and death rates in any planned intervention efforts.
In the Niger Delta of Nigeria, where oil exploration and extraction take place, oil spills have extensively contaminated the landscape, polluted the soil and water with toxins, and are believed to have severe health effects on the inhabitants of the area. Although there have been series of studies to access the impacts on the environment,,, little is known about the possible health effects on the people living near the contamination, especially women, most of who derive their livelihood from farming and fishing. However, there has been evidence in Nigeria and Kuwait that the burning of hydrocarbons has led to cancer, especially of the lungs. This finding, however, remains inconclusive as the claims are not sufficiently supported. In other to get to the root of the health problems in the Niger Delta region of Nigeria, it is important to identify the common types of gynecological lesion and their prevalence rates from a major specialist hospital that provides comprehensive healthcare services to inhabitants of the metropolitan city of Port Harcourt and the surrounding oil-producing rural areas. Models help make the most of limited data in the face of the challenges. Although modeling has become an important ally in our attempts to project future occurrence of diseases and can have a significant impact on our distribution of resources for purposes of control and prevention, much of this approach have not been effectively exploited in Nigeria and other developing countries. Knowledge of this information could form the basis for a comprehensive research study that may help identify the risk factors associated with the health of the inhabitants of the area and lay ground work for the implementation of disease control and prevention measures. This pilot study was aimed at determining the epidemiology of gynecological lesions among residents of an oil city in the Niger Delta region, and to use the data obtained to develop standardized prediction estimates for the diseases in 35-year time (2015–2050).
The objectives of this study were to determine the prevalence of gynecological lesions in Braithwaite Memorial Specialist Hospital (BMSH), Port Harcourt, Rivers State, Nigeria, and to use the information obtained to develop standardized prediction estimates for these lesions in 35-year time (2015–2050).
| Methods|| |
Study area and data source
Braithwaite Memorial Specialist Hospital (BMSH) was established in 1925. It is a government-owned hospital, named after a British doctor Eldred Curwen Braithwaite. It is in the old Government Reserved Area (Old GRA) in Port Harcourt, Rivers State, Nigeria. The hospital initially served as a medical facility for senior civil servants, later became a General Hospital and presently is a major Specialist Health Hospital with the mandate to deliver comprehensive healthcare services to the metropolitan city of Port Harcourt and the surrounding oil-producing rural areas of Rivers State and the Niger Delta region of Nigeria.
Rivers State is one of the six states that make up the South-South geopolitical zone of Nigeria. Rivers State lies at latitude 4°45' north and longitude 6°50' east and covers an area of 10,432.3 km2. As of 2010, the state had a population of 5,198,716 million with a density of 468 people/km2 and represented 3.7% of Nigeria's total population. Port Harcourt is the capital of Rivers State and one of Nigeria's leading industrial centers. The City lies at latitude 4°47'21” north and longitude 6°59'55” east, with a population of 1,382,592 million.
The natives of Rivers State are mainly farmers and fishermen, and they speak >23 main languages. The State is known as the treasure base of Nigeria due to its abundant oil and gas resources. Oil explorations in Rivers State began in 1956, and since then, there has been a paradigm shift in the occupation and life style of the natives resulting from reckless environmental pollution and industrialization. There is very little data quantifying the oil's impact on the health of people whose property, crops and livestock, drinking water, and air are polluted by oil, waste products from exploration and extraction, and extensive waste gas flaring.
Six hundred and ninety-seven (n = 697) gynecological lesion data were obtained from the archives of Histopathology Laboratory of BMSH. The data represent the number of females who received medical care including histopathological evaluation at the BMSH from 2010 to 2014 [Figure 1].
|Figure 1: Distribution of number of gynecological lesions by year of diagnosis|
Click here to view
Diagnosis of gynecological lesions
The data used for this study were based on lesions identified through histopathology screening by qualified pathologists and analyzed using the methods of Onyije et al. The major lesions identified include the following: adenocarcinoma, adenoma, adenomyosis, cervical polyp, chronic endometritis, cervical intraepithelial neoplasia, condyloma acuminatum, endometrial hyperplasia, endometrial polyp, leiomyoma, ovarian cyst, products of conception, and squamous cell carcinoma. Other minor lesions identified and classified under “others” in our study include the following: basal cell epithelioma, Brenner tumor, cervical cyst, chronic endocervicitis, chronic vulvitis, endometrial carcinoma, epidermal cyst, fibroma, hemangioma, ovaritis, batholin's cyst, vulval warts, vulvitis and yolk sac tumor (hepatoid variant). These lesions occurred very rarely and therefore were grouped for statistical convenience.
Preliminary analyses involved the descriptive statistics and frequency runs for the dependents and independent variables. Subsequently, to determine the relationships between the number of gynecological lesions occurring over the years, multiple linear regression analysis was conducted using the Fit Model and represented by the following prediction equation: ŶI = β0+ β1[year]I+ β2[Match…Lesion]i+εi, where Ŷ is the predicted or expected value of the dependent (response) variable for the ith observation; β0 is the intercept parameter, which correspond to the value of the response variable when the predictor is 0; β1 represents the change in the response variable given one-unit change in the predictor variable, year; β2 represents the change in the response variable given one-unit change in the second predictor variable, ith match lesion diagnosed; and εi is an error term representing deviation of the line defined by β0+ β1[year] + β2[Match… Lesions]. Data management, statistical analysis, and predictive modeling were performed using JMP statistical discovery™ software, version 12.0 (SAS Institute, Cary, NC, USA).
Ethical approval was granted by the ethics committee of BMSH through the Hospitals Management Board of Rivers State, Nigeria.
| Results|| |
Characteristics of sample population
The characteristics of the sample population used in the current study have been presented in detail elsewhere., In summary, a total of 697 gynecological lesions were diagnosed in the sample population with the majority (n = 689, 98.9%) occurring at the adults' stage. The mean age of the participants studied was 39.1 ± 12.8 years and most of the gynecological lesions (61.8%) were identified among females who were aged between 30 and 49 years. In general, the distribution of the lesions differed significantly (P < 0.001) by year of diagnosis, developmental stage, age category, and types of lesion. Gynecological lesions occurrence in the study population were similar between 2010 and 2012 and ranged from 150 (21.5%) to 158 (22.7%). The highest prevalence was in 2013, where 186 (26.7%) cases were reported, and the least number of cases were recorded in 2014 (n = 46, 6.6%).
Prediction equation model
The prediction equation model based on our study data with the corresponding match coefficient estimate for each gynecological lesion is presented on [Table 1]. The goodness of fit for the model as determined by the adjusted coefficient of determination (R2) was 0.781 with root mean square error of 10.529 and mean response value of 11.617.
|Table 1: Prediction equation expression and coefficient estimates for gynecological lesions|
Click here to view
Standardized rates and predicted estimates for diagnosed lesions, 2015–2050
The detailed summary of the gynecological lesions diagnosed among the subjects and the predicted estimates by type of lesions diagnosed over the 35-year period is presented in [Table 2]. The most prevalent lesion recorded over a 5-year period was leiomyoma (56%) with standardized mean rate of 0.508. This was followed by ovarian cyst, product of conception, and endometrial hyperplasia, which recorded standardized rates of 0.124, 0.075, and 0.044, respectively, over the 5-year period. The least diagnosed lesion was adenoma with standardized mean rate of 0.004. Based on the prevalence rates, it was estimated that incidence of leiomyoma among the patients' population will increase from 235 in 2015 to 706 cases by the year 2025, and by the year 2050, an estimated 1,883 females will be diagnosed with the disease. Similarly, ovarian cyst, which represented the second most common lesion, is projected to rise from an average estimate of 58 in 2015 to 173 by the year 2025, and by year 2050, 461 women will be diagnosed with this lesion. Product of conception, which was ranked third in prevalence rates, is expected to increase from 35 diagnosed cases to ~104 cases by the 2025, and subsequently, increased to 278 by the year 2050. In general, proportional increases are expected over the 35-year period on all other gynecological lesions identified in the sample population based on the standardized prevalence rates.
|Table 2: Summary of prediction model: standardized and predicted estimates of gynecological lesions|
Click here to view
| Discussion|| |
Gynecological lesions are public health problem, worldwide affecting all categories of females. It is a common cause of death in developed countries and among the leading causes of death in developing countries. Our study identified the top five gynecological lesions common among females attending BMSH in order of hierarchy as leiomyoma, ovarian cyst, product of conception, chronic cervicitis, and endometrial hyperplasia. These lesions are predicted to increase in the population to the range of 797%–815% in 35-year time. There has been little or no information on the prediction estimates of gynecological lesions in Nigerian tertiary hospitals. Therefore, our study is the first attempt at filling this knowledge gap, and we are hopeful that the data obtained will provide the needed basic information to engender interest among researchers and governmental agencies in addressing this important public health problem.
WHO reported that about 24.6 million people live with cancer worldwide. Parkin et al. reported that in indigenous Africans, 650,000 people of the estimated 965 million were diagnosed of cancer annually, and a lifetime risk of dying from cancer in African women was reported to be two times higher than in developed countries. In the United States, it was reported that leiomyoma-related hospitalized cases will rise from 37,134 in 2010 to 49,154 in 2050 with an increase of 22% in black women and 8% in white women. This is inconceivably lower when compared with the 801% increase (235–1,883 by 2050) reported in our current study for leiomyoma lesion, although the present research focused on one tertiary hospital.
Studies have shown that high incidence of leiomyoma occurs within the age of 35 years, and early menarche has also been identified as a factor.,,, According to Baird and Dunson, Parazzini, and Wise et al., parity and pregnancy are contributory factors to the rise in cases of leiomyoma. Other factors include caffeine intake and estrogen. Estrogen influences the growth of leiomyoma and decreased estrogen regresses its growth. Flake et al. reported high concentrations of estrogen receptor (at 6q25.1 and 14q) in leiomyomata than in other lesions. Estrogen dominance is a complex situation caused by excess exposure to environmental xenoestrogens (made up of hydrocarbons), which may arise from oil and gas exploration. Ngokere et al. has earlier reported increased estradiol and decreased progesterone in rabbits administered with Escravos crude oil. The use of synthetic estrogens, such as the birth control pill and hormone replacement therapy, anovulation which is common among women older than 35 years; unresolved emotional issues; poor diet; and negative lifestyle factors, such as smoking and alcohol, are also contributing factors.
Similarly, ovarian cyst which were predicted in this study to increase from 58 to 461 by 2050 is higher than the projection for Ireland as a country, where it was reported that ovarian cyst will increase from 407 cases in 2015 to 662 by 2040. Retained products of conception, which is the third highest predicted lesion in our study are associated with complication from labor and delivery. The retained tissue can cause prolonged postpartum hemorrhage and endometritis. The usual treatment is curettage, which results in further complications in 7% of patients, including uterine perforation, cervical laceration, and subsequent synechia formation. Retained products of conception are suspected when routine examination of the placenta at delivery reveals an incomplete placenta or when a patient has signs of endometritis or prolonged vaginal bleeding in the postpartum period.
Studies have shown that relationship exists between people living in close proximity to oil- and gas-contaminated areas and pregnancy complications, partly due to polluted sources of water by chemicals from the exploration and production of oil and gas., Hurtig and Sebastian reported in their study in Ecuador that miscarriages were found to be much more prominent in oil-contaminated areas with a risk of 2.34 times higher spontaneous abortion in communities situated near oil-contaminated environments. More than 60% of communities in Rivers State suffer the same fate as the case reported in Ecuador. Umunnakwe reported hydrocarbon leakages into grand water wells of two oil-producing communities (Obite and Egita) in Ogba, Rivers State, Nigeria. Similar report of extensive oil contamination of rivers, creeks, and ground water in Ogoni land in Rivers State was also given by Olof and Jonas. These reports tend to highlight the possible link of oil-contaminated environments with the prevalence of these lesions identified in our study. However, further research is needed to uncover the existence of such a relationship.
There are some limitations in our current study that may highlight opportunities for future method enhancement. The study was based on data collected from only one tertiary hospital, and thus, may not be representative of the actual prevalence of the various gynecological lesions in the general population. Also, several independent factors of interest including participants' occupation and race/ethnicity were not captured in the original data making it impossible to associate these factors with the distribution and predictive patterns. Consequently, while the predictive estimates obtained are the first of its kind in Nigeria, it is important to interpret the predicted prevalence rates of the diseases with caution as any effective intervention and control program may significantly alter these estimates in future.
| Conclusion|| |
Leiomyoma, ovarian cyst, and product of conception are the most prevalent gynecological lesions among patients receiving medical care at the BMSH and they have been predicted to increase alongside other lesions in the next 35 years. However, application of effective intervention and control measures such as alteration of life style (sexual behavior), vaccination against human papillomavirus (HPV), cytological screening, early clinical detection, and treatment and improved therapy could help reduce incidence and mortality rates associated with these diseases. In addition, healthcare physicians specializing in cancer care for women need to be alert to every opportunity to improve cancer screening and prevention among the growing and aging female populations in Nigeria, and other less-developed countries. More researches are needed to uncover the impact of oil and gas exploration, extraction, and environmental pollution on health outcomes in the oil-producing areas of Nigeria, and elsewhere around the world.
Financial support and sponsorship
The funding of the study was borne by the researchers.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Stoeldraijer L, Van DC, Van Wissen L. Janssen F. Impact of different mortality forecasting methods and explicit assumptions on projected future life expectancy: The case of the Netherlands. Dem Res 2013;29:323-54.
American Cancer Society (ACS). Global Cancer Facts & Figures 2007. Atlanta, Georgia, USA; American Cancer Society Publication.
Boyle P, Levin BE. World Cancer Report, International Agency for Research on Cancer (IARC). Lyon Press; 2008.
United Nations 2015 Press release. Available from: www.com.org/un/development/desa/population/event. [Last Retrieved on 2016 Feb 26].
Sylla BS, Christopher PW. A million Africans a year dying from cancer by 2030: What can cancer research and control offer to the continent? Int J Cancer 2012;130:245-50.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
Osakwe F. Cervical cancer screening: Second opinion may count. National Mirror Health. Available from: www.nationalmirronline.net. [Last Retrieved on 2016 Mar 24].
Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay JP. Cancer Incidence in Five Continents. International Agency for Research on Cancer (IARC); 1992:6. p. 920-7.
Pisani P, Bray F. Parkin DM. Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97:72-81.
Egwuatu VE, Ejeckam GC. 1980. An analysis of tumours of the female genital tract in Enugu Nigeria. A hospital based tumour registry review. Bull Cancer (Paris) 1980;67:535.
Ozumba BC, Nzegwu MA. Anyikam A. Histological patterns of gynecological lesions in Enugu, Nigeria. A five-year review from January 1, 2000 to December 31st
2004. Adv Biomed Res 2011;2:132-6.
Pindiga HU, El-Nafaty AU, Ekanem IA. Female genital malignancies in Maiduguri, Nigeria: A review of 328 cases. Trop J Obstet Gynecol 1999;16:52-62.
Seleye-Fubara D, Uzoigwe SA. Pattern of primary female genital cancer in port harcourt, Nigeria: A 12-year review. Sah Med J 2003;6:34-9.
Mohammed A, Ahmed SA, Oluwole OP, Avidime S. Malignant tumours of the female genital tract in Zaria, Nigeria: Analysis of 513 cases. Ann Afr Med 2006;5:93-6.
Agboola AO, Banjo AA, Abudu EK. Pattern of female genital malignancy in a semi-urban tertiary health centre. Nigerian Hosp Pract 2007;1:84-6.
Mazur MT, Kurman RJ. Diagnosis of Endometrial Biopsies and Curettings. A Practical Approach. 2nd
ed. New York: Springer Science + Business Media; 2005. p. 1-281.
Ordinioha B, Brisibe S. The human health implications of crude oil spills in the Niger delta, Nigeria: An interpretation of published studies. Niger Med J 2005;54:10-6.
Lindén O, Pålsson J. Oil contamination in Ogoniland, Niger Delta. Ambio 2013;42:685-701.
Ite AE, Udo JI, Ite MU, Sunday WP. Petroleum exploration and production: Past and present environmental issues in the Nigeria's Niger Delta. Am J Environ Protect 2013;1:78-90.
Kang HK, Levine PH, Mahan CM, Maillard JD, Simmens SJ, Young HA. Investigating the risk of cancer in 1990-1991 US Gulf war veterans with the use of state cancer registry data. Ann Epidemiol 2010;20:265-72.
Onyije FM, Eroje MA, Fawehinmi HB. Trends in Cervical cancer incidence in the university of Port Harcourt Teaching Hospital. Cont J Trop Med 2010;4:1-5.
Onyije FM, Ngokere AA, Mgbere OO, Ligha AE. The preponderance and dye-tissue receptive variability analyses of malignant and benign lesions of the female genitalia. J Oncol Sci 2017;3:12-7.
Onyije FM, Mgbere OO, Ngokere AA. Does oil and gas exploration pollution in the Niger Delta region of Nigeria Trigger gynecological disease? A preliminary assessment of cancerous and non-cancerous lesions in the female reproductive tract. APHA 2017 Annual meeting and Expo. Atlanta. Abstract # 380114, Board 5.
Abdulkareem F. Epidemiology and Incidence of Common Cancers in Nigeria; Cancer Registration and Epidemiology Workshop. April, 2009.
Wechter ME, Stewart EA, Myers ER, Kho RM, Wu JM. Leiomyoma-related hospitalization and surgery: Prevalence and predicted growth based on population trends. Am J Obstet Gynecol 2011;205:4921-5
Day BD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol 2003;188:100-7.
Schwartz SM. Epidemiology of uterine leiomyomata. Clin Obstet Gynecol 2001;44:316-26.
Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001;15:341-54.
Colditz GA. Epidemiology of breast cancer. Findings from the nurses' health study. Cancer 1993;71:1480-9.
Baird DD, Dunson DB. Why is parity protective for uterine fibroids? Epidemiology 2003;14:247-50.
Parazzini F. Risk factors for clinically diagnosed uterine fibroids in women around menopause. Maturitas 2006;55:174-9.
Wise LA, Palmer JR, Harlow BL. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: A prospective study. Am J Epidemiol 2004;159:113-23.
Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med 2010;28:204-17.
Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P. The genetic bases of uterine fibroids. A review. J Reprod Infertil 2011;12:181-91.
Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: A review. Environ Health Perspect 2003;111:1037-54.
Ngokere AA, Okoye JO, Obi E, Ibekailo SN, Awalu JC, Audu I. Anti-spermatogenic and estrogenic effects of Escravos crude oil in Chinchilla rabbits. Int J Biol Chem Sci 2014;8:1969-75.
Holly L. Estrogen Dominance: Too Much of a Good Thing Can Certainly Be BAD. Healing From Within Healthcare. Available from: http://www.naturopathic.org
. [Last Retrieved on 2016 Apr 28].
Cancer Projections for Ireland 2015-2040. Available from: www.ncri.ie/sites/ncri/files/pubs. [Last Retrieved on 2016 Feb 26].
Di Salvo DN. Sonographic imaging of maternal complications of pregnancy. J Ultrasound Med 2003;22:69-89.
Durfee SM, Frates MC, Luong A, Benson CB. The sonographic and color doppler features of retained products of conception. J Ultrasound Med 2005;24:1181-6.
Hurtig AK, Sebastián MS. Geographical differences in cancer incidence in the amazon basin of Ecuador in relation to residence near oil fields. Int J Epidemiol 2002;31:1021-7.
Armstrong B, Sebastián MS, Stephens C. Outcomes of pregnancy among women living in the proximity of oil fields in the amazon basin of Ecuador. Int J Occup Environ Health 2002;8:312-9.
Umunnakwe JE. Post impact studies of Hydrocarbon leakage into Ground water wells of Egita/Obite community, Rivers State, Nigeria. J Environ Earth Sci2015;5:67-80.
Olof L, Jonas P. Oil contamination in Ogoni land, Niger Delta. Ambio 2013;42:685-701.
[Table 1], [Table 2]